NeoGenomics (NEO) Competitors $8.72 -0.70 (-7.43%) Closing price 04/3/2025 04:00 PM EasternExtended Trading$8.73 +0.01 (+0.11%) As of 04/3/2025 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NEO vs. AMTM, RELY, MARA, TNET, CNXC, ATHM, STNE, ALIT, DXC, and CARGShould you be buying NeoGenomics stock or one of its competitors? The main competitors of NeoGenomics include Amentum (AMTM), Remitly Global (RELY), MARA (MARA), TriNet Group (TNET), Concentrix (CNXC), Autohome (ATHM), StoneCo (STNE), Alight (ALIT), DXC Technology (DXC), and CarGurus (CARG). These companies are all part of the "business services" industry. NeoGenomics vs. Amentum Remitly Global MARA TriNet Group Concentrix Autohome StoneCo Alight DXC Technology CarGurus Amentum (NYSE:AMTM) and NeoGenomics (NASDAQ:NEO) are both construction companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, dividends, community ranking, institutional ownership, risk, valuation, analyst recommendations and earnings. Does the media refer more to AMTM or NEO? In the previous week, Amentum had 2 more articles in the media than NeoGenomics. MarketBeat recorded 9 mentions for Amentum and 7 mentions for NeoGenomics. Amentum's average media sentiment score of 1.07 beat NeoGenomics' score of 0.54 indicating that Amentum is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Amentum 6 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NeoGenomics 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of AMTM or NEO? 39.9% of Amentum shares are held by institutional investors. Comparatively, 98.5% of NeoGenomics shares are held by institutional investors. 18.7% of Amentum shares are held by insiders. Comparatively, 1.3% of NeoGenomics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is AMTM or NEO more profitable? Amentum has a net margin of 0.00% compared to NeoGenomics' net margin of -11.92%. Amentum's return on equity of 0.00% beat NeoGenomics' return on equity.Company Net Margins Return on Equity Return on Assets AmentumN/A N/A N/A NeoGenomics -11.92%-2.10%-1.17% Does the MarketBeat Community prefer AMTM or NEO? NeoGenomics received 504 more outperform votes than Amentum when rated by MarketBeat users. Likewise, 70.81% of users gave NeoGenomics an outperform vote while only 37.50% of users gave Amentum an outperform vote. CompanyUnderperformOutperformAmentumOutperform Votes337.50% Underperform Votes562.50% NeoGenomicsOutperform Votes50770.81% Underperform Votes20929.19% Do analysts rate AMTM or NEO? Amentum currently has a consensus price target of $26.20, suggesting a potential upside of 43.22%. NeoGenomics has a consensus price target of $19.60, suggesting a potential upside of 124.77%. Given NeoGenomics' stronger consensus rating and higher possible upside, analysts plainly believe NeoGenomics is more favorable than Amentum.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amentum 0 Sell rating(s) 3 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.40NeoGenomics 0 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.80 Which has stronger earnings & valuation, AMTM or NEO? Amentum has higher revenue and earnings than NeoGenomics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmentum$9.82B0.45-$82MN/AN/ANeoGenomics$660.57M1.70-$87.97M-$0.62-14.06 SummaryAmentum beats NeoGenomics on 8 of the 15 factors compared between the two stocks. Remove Ads Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NEO vs. The Competition Export to ExcelMetricNeoGenomicsTesting laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.14B$4.65B$5.58B$7.57BDividend YieldN/A1.49%5.35%4.04%P/E Ratio-14.358.8922.9818.19Price / Sales1.732.01362.8486.44Price / Cash27.0321.2138.1634.64Price / Book1.274.546.534.03Net Income-$87.97M$107.05M$3.21B$247.18M7 Day Performance-6.12%-1.48%-5.84%-5.61%1 Month Performance-7.10%-18.22%-0.12%-6.72%1 Year Performance-40.15%-44.58%6.42%-3.53% NeoGenomics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NEONeoGenomics3.3558 of 5 stars$8.72-7.4%$19.60+124.8%-41.4%$1.12B$660.57M-14.062,100Short Interest ↑Positive NewsGap DownHigh Trading VolumeAMTMAmentum2.4691 of 5 stars$18.18+0.6%$26.20+44.1%N/A$4.42B$9.82B0.0053,000News CoveragePositive NewsGap DownRELYRemitly Global2.986 of 5 stars$20.80-0.6%$28.13+35.2%-2.4%$4.17B$1.26B-109.472,700Analyst ForecastGap DownMARAMARA3.4549 of 5 stars$11.50-7.8%$22.80+98.3%-42.2%$3.98B$656.38M14.569Gap DownTNETTriNet Group4.5112 of 5 stars$79.09+0.0%$105.67+33.6%-42.2%$3.92B$5.05B23.133,600Ex-DividendPositive NewsGap DownCNXCConcentrix4.6675 of 5 stars$55.64-2.3%$69.60+25.1%-12.3%$3.58B$9.59B15.00315,000Analyst RevisionGap DownATHMAutohome2.9755 of 5 stars$27.80+0.2%$32.00+15.1%+3.2%$3.37B$7.04B15.035,360News CoveragePositive NewsSTNEStoneCo4.8431 of 5 stars$10.48-4.6%$14.50+38.4%-30.2%$3.24B$12.74B8.1917,091Positive NewsALITAlight3.8165 of 5 stars$5.94+0.3%$10.19+71.7%-44.2%$3.22B$2.33B-19.7816,000Gap DownDXCDXC Technology3.3156 of 5 stars$17.080.0%$21.29+24.7%-22.2%$3.09B$13.09B-40.66130,000Positive NewsCARGCarGurus3.8203 of 5 stars$29.13+1.1%$38.75+33.0%+19.8%$3.04B$894.38M161.841,200News CoverageGap Down Remove Ads Related Companies and Tools Related Companies Amentum Alternatives Remitly Global Alternatives MARA Alternatives TriNet Group Alternatives Concentrix Alternatives Autohome Alternatives StoneCo Alternatives Alight Alternatives DXC Technology Alternatives CarGurus Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NEO) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeoGenomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeoGenomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NEO Stock Free NEO Stock Alerts